In 2018, Elastagen was acquired by global biopharma Allergan for $US95 million with a further $120 million in milestones.

The Company’s lead program targets the development of an injectable product for tissue augmentation.

Brandon Capital is aware of scammers impersonating us - offering jobs and asking for bank details. We do not offer employment or ask for banking details via SMS, websites or phone calls. Do not provide any details and report to the relevant authorities in your location.